Goldman Sachs’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
Other funds holding HSTO
MIH
VF
UCFA
N
Goldman Sachs's HSTO Position: Q3 2021 in Review
Goldman Sachs sold out of Histogen Inc. Common Stock (HSTO) in Q3 2021, closing a stake of 1,567 shares — an estimated $34K sold.
Goldman Sachs first reported a position in HSTO in Q3 2013 and held it in 19 quarters. The position peaked at $1.79M in Q2 2018. 22 funds tracked by Wall St. Rank hold HSTO as of Q3 2021.
- Goldman Sachs reported no remaining Histogen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- Goldman Sachs sold 1,567 Histogen Inc. Common Stock shares in Q3 2021, an estimated $34K.
- Goldman Sachs first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 19 quarters.
- Goldman Sachs's Histogen Inc. Common Stock position peaked at $1.79M in Q2 2018.
- 22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2021.
Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.